A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

NCT03812263 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukocyte Adhesion Defect - Type I

Interventions

BIOLOGICAL: RP-L201

Sponsor

Rocket Pharmaceuticals Inc.

Collaborators

[object Object]